2625 related articles for article (PubMed ID: 11902584)
1. Hypoxia--a key regulatory factor in tumour growth.
Harris AL
Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
[TBL] [Abstract][Full Text] [Related]
2. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.
Makino Y; Cao R; Svensson K; Bertilsson G; Asman M; Tanaka H; Cao Y; Berkenstam A; Poellinger L
Nature; 2001 Nov; 414(6863):550-4. PubMed ID: 11734856
[TBL] [Abstract][Full Text] [Related]
4. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
Vandenbunder B
Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
[TBL] [Abstract][Full Text] [Related]
5. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
6. Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.
Qin C; Wilson C; Blancher C; Taylor M; Safe S; Harris AL
Clin Cancer Res; 2001 Apr; 7(4):818-23. PubMed ID: 11309328
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition.
Jeong CH; Lee YM; Choi KS; Seong YR; Kim YJ; Im DS; Kim KW
Int J Oncol; 2005 Jan; 26(1):211-6. PubMed ID: 15586242
[TBL] [Abstract][Full Text] [Related]
8. [The hypoxia-inducible factor HIF as a new target in cancer research].
L'Allemain G
Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression.
Camenisch G; Stroka DM; Gassmann M; Wenger RH
Pflugers Arch; 2001 Nov; 443(2):240-9. PubMed ID: 11713650
[TBL] [Abstract][Full Text] [Related]
10. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
11. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.
Maltepe E; Schmidt JV; Baunoch D; Bradfield CA; Simon MC
Nature; 1997 Mar; 386(6623):403-7. PubMed ID: 9121557
[TBL] [Abstract][Full Text] [Related]
12. The Id proteins and angiogenesis.
Benezra R; Rafii S; Lyden D
Oncogene; 2001 Dec; 20(58):8334-41. PubMed ID: 11840326
[TBL] [Abstract][Full Text] [Related]
13. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
[TBL] [Abstract][Full Text] [Related]
15. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.
Giatromanolaki A; Harris AL
Anticancer Res; 2001; 21(6B):4317-24. PubMed ID: 11908686
[TBL] [Abstract][Full Text] [Related]
16. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
Choi H; Chun YS; Kim SW; Kim MS; Park JW
Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
[TBL] [Abstract][Full Text] [Related]
18. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.
Papandreou I; Krishna C; Kaper F; Cai D; Giaccia AJ; Denko NC
Cancer Res; 2005 Apr; 65(8):3171-8. PubMed ID: 15833847
[TBL] [Abstract][Full Text] [Related]
19. Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney.
Freeburg PB; Abrahamson DR
J Am Soc Nephrol; 2004 Oct; 15(10):2569-78. PubMed ID: 15466261
[TBL] [Abstract][Full Text] [Related]
20. Building better vasculature.
Bruick RK; McKnight SL
Genes Dev; 2001 Oct; 15(19):2497-502. PubMed ID: 11581154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
